Stocks Consumer discretionary BYAH
NASDAQ · Consumer discretionaryPark Ha Biological Technology Co., Ltd. (BYAH)
Park Ha Biological Technology Co., Ltd. reported revenue of $2.5M in fiscal 2025, up 6.0% from a year earlier. It posted a net loss of $24.4M. In fiscal 2025 capital spending exceeded operating cash flow by $3K. At October 31, 2025 it held $3.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on May 15, 2026.
Key facts about Park Ha Biological Technology Co., Ltd.
- Net worth
- Park Ha Biological Technology Co., Ltd. has a market value (market cap) of $3.5M at the latest share price, and shareholders' equity of $4M on its balance sheet at October 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.5M (+6.0% year on year), with a net loss of $24.4M.
- Cash flow
- In fiscal 2025 operations brought in $85.9K of cash; after $88.8K of capital spending, free cash flow was -$3K.
- Latest report
- The latest periodic report (annual report (foreign issuer, amended), 20-F/A) was filed with the SEC on May 15, 2026 and covers the period to October 31, 2025. Open on SEC EDGAR
What Park Ha Biological Technology Co., Ltd. does
Park Ha Biological Technology Co., Ltd. is registered with the SEC under industry code SIC 2840 (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics). Its shares trade on NASDAQ under the ticker BYAH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.5M | -$24.4M | -$41.38 | -$3K |
| 2024 | $2.4M | $478.6K | $0.96 | $874.9K |
| 2024 | $2.5M | $852K | $1.70 | $103.9K |
| 2022 | $1.9M | $191.3K | $0.57 | $1.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where BYAH ranks in Consumer discretionary
Latest SEC filings
What Park Ha Biological Technology Co., Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 11, 2026
- September 2, 2026
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running Park Ha Biological Technology Co., Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 3, 2026 | Zhu XiaoyanCFO | Received as pay | 112,500 | $20.3K |
Who owns BYAH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Corin Global Partners Holdings Limited13G, passive with 1 related filers | 9.8% | August 10, 2026 |
| Fusen Advertising Design Limited13G, passive with 1 related filers | 9.8% | August 10, 2026 |
| Peverel Summit Holdings Limited13G, passive with 1 related filers | 9.8% | August 10, 2026 |
| Rove Trading Co., Limited13G, passive with 1 related filers | 9.8% | August 10, 2026 |
| Velociti Group Limited13G, passive with 1 related filers | 9.8% | August 10, 2026 |
| Motovance Holdings Limited13G, passive with 1 related filers | 9.7% | August 13, 2026 |
| Nexera Technology Company Limited13G, passive with 1 related filers | 9.1% | August 10, 2026 |
| Pinnacle International Holding Limited13G, passive with 1 related filers | 7.6% | August 10, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 112,500 shares in total, about $166.5K at the last price.
| Holder | Shares |
|---|---|
| Zhu XiaoyanCFO | 112,500 |
Questions about BYAH
What does Park Ha Biological Technology Co., Ltd. do?
Park Ha Biological Technology Co., Ltd. is a company in the Consumer discretionary sector, listed on NASDAQ as BYAH. Its shares trade on NASDAQ under the ticker BYAH.
What is Park Ha Biological Technology Co., Ltd.'s net worth?
Park Ha Biological Technology Co., Ltd. has a market value (market cap) of $3.5M at the latest share price, and shareholders' equity of $4M on its balance sheet at October 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Park Ha Biological Technology Co., Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $24.4M on revenue of $2.5M.
How much revenue does Park Ha Biological Technology Co., Ltd. make?
In fiscal 2025 Park Ha Biological Technology Co., Ltd. reported revenue of $2.5M. That is 6.0% more than a year earlier.
When did Park Ha Biological Technology Co., Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on May 15, 2026. It covers the period to October 31, 2025. Its newest filing of any kind is the foreign issuer update from September 11, 2026.
Similar companies
Compare BYAH with
Follow BYAH
Get an email when Park Ha Biological Technology Co., Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Park Ha Biological Technology Co., Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.